Charlotte Kirby Charlotte Kirby

Small businesses lack mobile device security policies

Smaller businesses lack the tech resources of larger ones so it's common practice that they not only allow employees to use their personal mobile phones to complete work tasks but in many cases actively expect them to.

Read More
Charlotte Kirby Charlotte Kirby

An industry leader’s perspective on the complexity of scientific data

In this article, Dr Raminderpal Singh speaks to Janette Thomas of Five Alarm Bio for a biotech CEO’s perspective on the complexity of data faced by both large and small biotechs. Janette is on a mission to develop drugs targeting the chronic diseases associated with ageing. She shares her insights on the challenges and opportunities in the biotech sector, particularly for early-stage companies, and how the industry can better harness data and technology to drive innovation.

Read More
Charlotte Kirby Charlotte Kirby

Bloomberg lauds Cambridge tech stars in UK Startup pantheon

Three companies with Cambridge connections – two based in the city – have been named by Bloomberg among its 25 Startups to Watch. Cambridge based Sano Genetics and Secondmind are in the pantheon along with Wayve whose founder and CEO completed his PhD at The University of Cambridge.

Read More
Charlotte Kirby Charlotte Kirby

Female-founded technology platform Where You At raises £2.5 million in pre-seed funding round

Where You At (WYA), is a female-founded mesh technology platform designed to help make congested events safer. It uses indoor mapping and mesh hardware to help users stay connected in busy events, enabling people to communicate even when there is no phone signal. It has raised significant funding which has helped it make a huge impact in a short space of time.

Read More
Charlotte Kirby Charlotte Kirby

Cardiff-based Antiverse secures €4.2 million to advance generative AI antibody design

Antiverse, a techbio company designing antibodies for challenging targets, has announced the successful closure of €4.2 million seed funding round. This latest investment brings the company’s total equity financing to €8.6 million, marking a significant step in its mission to revolutionize antibody design using generative AI technology.

Read More